SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
SARS drug ready for clinical trial
Fri April 3rd - A drug developed to treat lung disease has shown early promise against the Covid-19 virus, researchers reported last night. More
'Promising' COVID-19 vaccine revealed
Fri April 3rd - A potential vaccine for COVID-19 has been described for the first time after promising mice studies, US scientists have revealed today (2 April 2020). More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

No link to moderate egg intake and CVD

Thursday March 5th, 2020

Moderate egg intake is not associated with cardiovascular disease (CVD) risk, while taking fish oil supplements is linked to a lower risk of heart disease, according to two studies published today.

The association between egg intake and CVD risk has been a topic of debate over the past decade but the report in the latest edition of The BMJ found no overall association.

A team of USA-based researchers examined data from three large US cohort studies: The Nurses’ Health Study (NHS), the NHS II, and the Health Professionals’ Follow-Up Study (HPFS). These included 83,349 female nurses aged 30-55; 90,214 female nurses aged 25-44; and 42,055 male health professionals aged 40-75, respectively, who were free of CVD, type 2 diabetes and cancer at the start of the study.

During the follow up period, 14,806 cases of CVD were recorded, including 9,010 cases of coronary heart disease and 5,903 cases of stroke.

The researchers established that most people ate between one to five eggs per week, and those with a higher egg intake had a higher BMI, were less likely to be treated with statins, and ate more red meat.

After adjusting for age, lifestyle, and dietary factors, no association was found between egg intake and risk of CVD.

Results from an updated meta-analysis of 28 observational studies further support the overall lack of an association between egg intake and CVD risk, but evidence varied between studies conducted in the US, Europe and Asia.

The BMJ also publishes the findings of an observational study by researchers in China and the USA into the link between fish oil supplements and CVD.

Drawing data from the UK Biobank - a large population based study of more than half a million British men and women - the analysis included 427,678 men and women aged between 40 and 69 years old, without CVD or cancer, who were enrolled in the study from 2006 to 2010 and completed a questionnaire on supplement use.

Almost a third of participants reported taking regular fish oil supplements at the start of the study and the researchers found that these were associated with a 13% lower risk of all-cause mortality, a 16% lower risk of CVD mortality, and a 7% lower risk of CVD events.

They also found that the association between fish oil use and CVD events appeared to be stronger among those with high blood pressure.

The researchers conclude that habitual fish oil use “is associated with a lower risk of all-cause and CVD mortality and a marginal benefit against CVD events among the general population”.

Drouin-Chartier JP, Chen S, Li Y et al. Eggs consumption and risk of cardiovascular disease: findings from three large prospective US cohort studies and a systematic review and updated meta-analysis. BMJ 5 March 2020.

https://www.bmj.com/content/368/bmj.m513

Li ZH, Zhong WF, Liu S et al. Associations of habitual fish oil supplementation with cardiovascular outcomes and all-cause mortality: evidence from a large population based cohort study. BMJ 5 March 2020.

https://www.bmj.com/content/368/bmj.m456

Tags: Asia | Diet & Food | Heart Health | North America | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES